The 5xFAD mouse model used in the current study is characterized by increased APP expression early in life, modeling familial AD, with pronounced, early amyloid pathology, neuronal loss (33, 56), and changes in spine density in the somatosensory and prefrontal cortex by ∼6 months of age (57). Here, APP is linked to amyloidosis.